“…All actions, including the cardiovascular actions of VP and OT, are mediated via specific, very similar, membrane G protein linked receptors, widely distributed in the body . The majority of central nervous system actions [35][36][37][38][39][40] and of the peripheral actions of VP including vasoconstriction [41,42], glycogenolysis [43,44] adrenal angiotensin II secretion [45] and platelet adhesion [46] are mediated via type 1 receptors (V1aR), coupled to a Gq/11 protein, phospholipases C, D and A2 as well as intracellular calcium increase [22,23]. In the kidneys, VP binds to type 2 receptors (V2R) coupled to cAMP production, and control aqaporin-2 (Aqp-2) gene expression and synthesis, affecting water reabsorption and urine concentration [47,48].…”